✦ LIBER ✦

PCN16 Clinical Effectiveness Analysis of Sunitinib for the Treatment of Pancreatic Neuroendocrine Tumors

✍ Scribed by J. Walczak; J. Jarosz; M. Lipińska; P. Prząda-Machno; J. Kroc

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib Malate for the Treatment of Pa

✍ Raymond, Eric; Dahan, Laetitia; Raoul, Jean-Luc; Bang, Yung-Jue; Borbath, Ivan; 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 956 KB

PCN61 Cost-Effectiveness of Sunitinib +

✍ Chi-Chan, A.; Gutiérrez-Colín, C.I.; Peniche-Otero, G.; Herrera-Rojas, J.; Muciñ 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN93 Treatment of Well-Differentiated P

✍ J. Walczak; M. Garbacka; J. Zawieja; P. Prząda-Machno; J. Kroc 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN63 Cost-Effectiveness of Sunitinib in

✍ Soares, M.; Inês, M.; Contente, M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Everolimus for the treatment of pancreat

✍ Feldmann, Georg; Bisht, Savita; Schütte, Ute; Haarmann, Jens; Brossart, Peter 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 319 KB

FDA Approval Summary: Sunitinib for the

✍ Blumenthal, G. M.; Cortazar, P.; Zhang, J. J.; Tang, S.; Sridhara, R.; Murgo, A. 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 137 KB